Mark Yarchoan
@MarkYarchoan
Followers
2K
Following
420
Statuses
568
Physician scientist @JohnsHopkins @hopkinskimmel @CMM_JHU, focused on translational immunotherapy research for #HCC, #cholangiocarcinoma
Baltimore, MD
Joined March 2018
@VPrasadMDMPH Aiming for more ROI from science funding is a goal that we should all support But please don’t use bad pseudo “science”/Twitter scientists/politicians masquerading as scientists and university politics as a reason to burn the whole system of medical science down
0
0
1
One unintended consequence is that basic and clinical research—which rely more on university resources for technology and infrastructure—may be disadvantaged compared to social sciences
0
0
2
RT @pashtoonkasi: As we use novel therapies, important to recognize and learn about side effects that can be a challenge. 👇🏽Calciphylaxis…
0
5
0
With the immediate cut to indirects, Universities will require MDs to do more clinical medicine to supplement salaries The number of MDs doing translational science is already too low
0
3
33
@VPrasadMDMPH Maybe serving on an R01 study section should be a requisite for receiving NIH funding - so the study sections could all have their choice of members
0
0
2
RT @ShaalanBeg: Is 2025 going to be the year Pan-RAS inhibitors make it into the clinic? Pan-RAS inhibitor shows early/deep molecular res…
0
40
0
RT @Erman_Akkus: 💊Pan-RAS inhibitor Daraxonrasib in 2L of pancreatic cancer #GI25 @ASCO ✅ORR KRAS G12X: 36%, RAS mt: 27% ➡️For compariso…
0
36
0
@MohitKasibhatla @ChesterKao1 @SorenCharmsaz @wonjinho1 @DrLizJaffee @mnakazawa7 @evanlipson @marinabaretti @JCensits Unfortunately we only collected height/weight so did not distinguish visceral fat
0
0
0
@SPilleron @ChesterKao1 @SorenCharmsaz @wonjinho1 @DrLizJaffee @mnakazawa7 @evanlipson @marinabaretti @JCensits Patient followed perspectively from start of IO therapy (day 0). I can think of several paradoxes in cancer. Smokers develop more lung CA but have better lung cancer outcomes with IO for example (due to higher TMB)…
1
0
3
@MarcusDGon @ChesterKao1 @SorenCharmsaz @wonjinho1 @DrLizJaffee @mnakazawa7 @evanlipson @marinabaretti @JCensits These patients were excluded. We looked at obese versus normal weight
0
0
1
@ProtonStorey @ChesterKao1 @SorenCharmsaz @wonjinho1 @DrLizJaffee @mnakazawa7 @evanlipson @marinabaretti @JCensits We have examined age (manuscript soon from @danielzabransky ) but not the intersection. We should look at this - thanks
1
0
1
0
0
2
RT @jitcancer: New #JITC article: Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade
0
17
0
RT @LesinskiLab: Calling all #postdocs!!!! @WinshipAtEmory wants YOU! Please apply if interested in exploring our collaborative environmen…
0
2
0
RT @ArndtVogel: 🔥 FDA grants accelerated approval to zanidatamab- for previously treated unresectable or metastatic HER2-positive biliary t…
0
26
0
RT @HopkinsMedNews: Entinostat + Nivolumab Yields Durable Results in Some Pancreatic Cancer Patients. @marinabaretti @HealthDayTweets https…
0
2
0